NCT03036930: A trial that was reported late by National Cancer Institute (NCI)
This trial has reported, although it was 260 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03036930 |
|---|---|
| Title | Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 23, 2017 |
| Completion date | March 4, 2024 |
| Required reporting date | March 4, 2025, midnight |
| Actual reporting date | Nov. 19, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 260 |